Non-alcoholic fatty liver disease and dyslipidemia: An update
Niki Katsiki(Neurosciences Institute), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Dimitri P. Mikhailidis(Neurosciences Institute)
Cited by 576
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k